AI assistant
Elevance Health, Inc. — Director's Dealing 2015
Apr 15, 2015
29933_dirs_2015-04-15_3c418434-f56b-48b5-9acb-8614fae873bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2015-04-13
Reporting Person: NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-13 | Common Stock | M | 46667 | $76.59 | Acquired | 157639.51 | Direct |
| 2015-04-13 | Common Stock | M | 2673 | $30.10 | Acquired | 160312.51 | Direct |
| 2015-04-13 | Common Stock | S | 14508 | $154.29 | Disposed | 145804.51 | Direct |
| 2015-04-13 | Common Stock | S | 34832 | $155.06 | Disposed | 110972.51 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-04-13 | Employee Stock Option (Right to Buy) | $76.59 | M | 46667 | Disposed | 2016-03-01 | Common Stock (46667) | Direct |
| 2015-04-13 | Employee Stock Option (Right to Buy) | $30.10 | M | 2673 | Disposed | 2016-03-02 | Common Stock (2673) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2015.
F2: This transaction was executed in multiple trades at prices ranging from $153.78 to $154.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
F3: This transaction was executed in multiple trades at prices ranging from $154.79 to $155.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
F4: The option, representing a right to purchase a total of 66,667 shares, became exercisable in five equal semi-annual installments of 11,111 shares each and one semi-annual installment of 11,112 shares beginning on September 1, 2006, which was the six-month anniversary of the date on which the option was granted.
F5: The option, representing a right to purchase a total of 92,285 shares, became exercisable in one semi-annual installment of 15,380 shares and five equal semi-annual installments of 15,381 shares each beginning on September 2, 2009, which was the six-month anniversary of the date on which the option was granted.